ESR1 and breast carcinoma: CLA display the estrogen antagonistic activities through the inhibition of the ERa-mediated signaling in ER-positive MCF-7 human breast cancer cells; unlike MCF-7 cells, the inhibitory effects of CLA on cell growth were weak or lost in ER-negative MDA-MB-231 breast cancer cells.